Early research (Phase 1)Study completedNCT00049296What this trial is testingThalidomide and Docetaxel in Treating Patients With Advanced CancerWho this might be right forCancer Case Comprehensive Cancer Center 26
Testing effectiveness (Phase 2)Looking for participantsNCT05150691What this trial is testingA Phase 1/2a Study of DB-1303/BNT323 in Advanced/Metastatic Solid TumorsWho this might be right forHER2-positive Advanced Solid Tumor DualityBio Inc. 796
Not applicableStudy completedNCT00428220What this trial is testingA Continuation Study Using Sunitinib Malate For Patients Leaving Treatment On A Previous Sunitinib Study.Who this might be right forMetastatic Breast CancerAdvanced Breast CancerMetastatic Castration Resistant Prostate Cancer+9 more Pfizer 223
Early research (Phase 1)Study completedNCT04430842What this trial is testingDose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of QBS10072SWho this might be right forAstrocytomaBrain CancerBrain Metastases+20 more Quadriga Biosciences, Inc. 15
Early research (Phase 1)Study completedNCT04319757What this trial is testingACE1702 in Subjects With Advanced or Metastatic HER2-expressing Solid TumorsWho this might be right forLocally Advanced Solid TumorMetastatic CancerSolid Tumor+2 more Acepodia Biotech, Inc. 12
Not applicableActive Not RecruitingNCT04314401What this trial is testingNational Cancer Institute "Cancer Moonshot Biobank"Who this might be right forAcute Myeloid LeukemiaAnatomic Stage III Breast Cancer AJCC v8Anatomic Stage IV Breast Cancer AJCC v8+26 more National Cancer Institute (NCI) 1,600
Early research (Phase 1)Study completedNCT03849469What this trial is testingXmAb®22841 Monotherapy & in Combination w/ Pembrolizumab in Subjects w/ Selected Advanced Solid TumorsWho this might be right forMelanomaCervical CarcinomaPancreatic Carcinoma+20 more Xencor, Inc. 78
Early research (Phase 1)Active Not RecruitingNCT04491942What this trial is testingTesting the Addition of an Anti-cancer Drug, BAY 1895344, to the Usual Chemotherapy Treatment (Cisplatin, or Cisplatin and Gemcitabine) for Advanced Solid Tumors With Emphasis on Urothelial CancerWho this might be right forAdvanced Bile Duct CarcinomaAdvanced Breast CarcinomaAdvanced Cervical Carcinoma+31 more National Cancer Institute (NCI) 74
Testing effectiveness (Phase 2)UnknownNCT03475953What this trial is testingA Phase I/II Study of Regorafenib Plus Avelumab in Solid TumorsWho this might be right forColorectal Cancer Not MSI-H or MMR-deficientGISTOesophageal or Gastric Carcinoma+12 more Institut Bergonié 747
Testing effectiveness (Phase 2)Study completedNCT04068896What this trial is testingStudy of NGM120 in Subjects With Advanced Solid Tumors, Pancreatic Cancer, and Prostate Cancer Using Combination TherapyWho this might be right forPancreatic CancerMetastatic Castration-resistant Prostate CancerBladder Cancer+8 more NGM Biopharmaceuticals, Inc 89
Not applicableLooking for participantsNCT03452774What this trial is testingSYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and RegistryWho this might be right forCancer, MetastaticCancerCancer of Pancreas+40 more Massive Bio, Inc. 50,000
Early research (Phase 1)Study completedNCT00635596What this trial is testingPhase I Study of MT110 in Lung Cancer (Adenocarcinoma and Small Cell), Gastric Cancer or Adenocarcinoma of the Gastro-Esophageal Junction, Colorectal Cancer, Breast Cancer, Hormone-Refractory Prostate Cancer, and Ovarian CancerWho this might be right forSolid Tumors Amgen Research (Munich) GmbH 65
Not applicableStudy completedNCT00477919What this trial is testingE-MOSAIC Electronic Tool to Monitor SymptomsWho this might be right forCancer Swiss Cancer Institute 264
Early research (Phase 1)Ended earlyNCT04060342What this trial is testingGB1275 Monotherapy and in Combination With an Anti-PD1 Antibody in Patients With Specified Advanced Solid Tumors or in Combination With Standard of Care in Patients With Metastatic Pancreatic AdenocarcinomaWho this might be right forPancreatic AdenocarcinomaEsophageal AdenocarcinomaEsophageal Squamous Cell Carcinoma+11 more GB006, Inc., a wholly owned subsidiary of Gossamer Bio, Inc. 61
Testing effectiveness (Phase 2)Study completedNCT04892342What this trial is testingStudy of ESG401 in Adults With Solid TumorsWho this might be right forNeoplasms, BreastNeoplasms, LungNeoplasms,Colorectal+3 more Shanghai Escugen Biotechnology Co., Ltd 156
Testing effectiveness (Phase 2)Ended earlyNCT04032704What this trial is testingLadiratuzumab Vedotin in Advanced Solid TumorsWho this might be right forSmall Cell Lung CancerNon-small Cell Lung Cancer, SquamousNon-small Cell Lung Cancer, Non-squamous+6 more Seagen Inc. 205
Testing effectiveness (Phase 2)Ended earlyNCT05363605What this trial is testing[225Ac]-FPI-1966 in Participants With Advanced Solid TumoursWho this might be right forAdvanced Solid TumorHead and Neck Squamous Cell CarcinomaBladder Carcinoma+11 more Fusion Pharmaceuticals Inc. 6
Not applicableStudy completedNCT07059598What this trial is testingRelationship of Nutritional Status to Chemotherapy Treatment Completion and Outcomes in Cancer PatientsWho this might be right forCancer-related Malnutrition Abbott Nutrition 209
Early research (Phase 1)Active Not RecruitingNCT05215574What this trial is testingStudy of NGM831 as Monotherapy and in Combination With Pembrolizumab or Pembrolizumab and NGM438 in Advanced or Metastatic Solid TumorsWho this might be right forPancreatic CancerBreast CancerGastric Cancer+13 more NGM Biopharmaceuticals, Inc 130
Early research (Phase 1)Study completedNCT02892123What this trial is testingTrial of ZW25 (Zanidatamab) in Patients With Advanced HER2-expressing CancersWho this might be right forHER2-expressing Cancers Jazz Pharmaceuticals 279